PET using a new voltage-sensitive tracer displayed promise for analyzing activity inside the mitochondria of lung cancer tumors, information that may be valuable for predicting a patient's response to treatment.

A new report published in Radiology: Cardiothoracic Imaging offers guidance for radiologists to help identify vaping product use-associated lung injury, analyzing recent cases and best practices.

Los Altos, California-based HeartVista has gained approval from the Food and Drug Administration for its one-click heart MRI examination tool. 

Facebook and the NYU School of Medicine made headlines back in August 2018 when they announced their plan to improve MRI times using AI.

Experts with Charité – Universitätsmedizin Berlin have developed a new diagnostic technique to let doctors visualize liver tumors using “tomoelastography,” which combines tomography and elasticity.

A team of Swedish researchers found that a hybrid planar and SPECT imaging method fell short in accurately measuring the absorbed treatment dose in some patients, but importantly, performed well in those with bone marrow metastases.

As of now the Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has enrolled 16,505 participants across a number of certified mammography clinics in the U.S., Canada and Argentina, with more sites and participants to come.

Canadian Nuclear Laboratories and TRIUMF, the country’s particle accelerator center, have successfully produced actinium-225—a rare isotope that can be used for novel cancer therapy treatments.